Sema GLP-1 (Dry) 5mg

Sema GLP-1 (Dry Powder Formulation) Single-Action GLP-1 Therapy in a Compounded, Convenient Format

Sema GLP-1, in its compounded dry powder formulation, offers physicians a reliable and customizable single-action GLP-1 receptor agonist for weight management and metabolic care. This formulation is preservative-free, with the added benefit of longer shelf life and flexible dosing through reconstitution.

As a GLP-1 mono-agonist, Sema GLP-1 mimics the body’s natural incretin response—enhancing satiety, reducing appetite, and improving glycemic control—making it a trusted therapeutic option for patients with obesity, prediabetes, or type 2 diabetes.

Why Choose Sema GLP-1 in Dry Powder Form?

• Single-action mechanism: Targets the GLP-1 receptor to regulate appetite and support blood sugar control
• Customizable therapy: Titrated based on individual patient response and tolerability
• Longer shelf life: Dry powder format is stable, with easy reconstitution for weekly use
• Clean formulation: No preservatives—ideal for simplified, allergy-conscious protocols
• Practice efficiency: Cost-effective, personalized solution that integrates seamlessly into clinical workflows

Clinical Benefits:

• Reduced appetite and food intake
• Slower gastric emptying and improved satiety
• Enhanced insulin sensitivity and fasting glucose control
• Well-established safety profile as a GLP-1 mono-therapy
• Suitable for medically supervised weight loss and metabolic programs

Formulation: Dry powder for reconstitution; administered as a weekly subcutaneous injection

Availability: Compounded by licensed pharmacies for patient-specific prescriptions

Offer your patients a proven, single-pathway solution with the flexibility of a compounded dry powder—designed for modern, personalized metabolic care.